{'fraction_non_alphanumeric': 0.03460207612456748, 'fraction_numerical': 0.02191464821222607, 'mean_word_length': 5.2, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Evaluation of prognostic nutritional index (PNI) as a prognostic indicator in multimodal treatment for gynecological cancer patients].

We assessed the usefulness of PNI (PNI = 10 x serum albumin + 0.005 x peripheral lymphocytes) as a prognostic indicator and determinant of multimodal treatment for 30 gynecological patients (control group: 12 patients with gynecological benign disease; good prognostic group: 10 with more than two-year survival having gynecological cancer; poor prognostic group: 8 with less than one-year survival having gynecological cancer). It was concluded that 1) PNI of the poor prognostic group was significantly lower than that of good prognostic group and control group (p < 0.01); 2) PNI is effective as a prognostic indicator; and 3) PNI is useful in clinical practice as a determinant of the multimodal treatment and high risk group.